GE HealthCare Technologies (GEHC) Cost of Revenue (2022 - 2026)

GE HealthCare Technologies (GEHC) has reported Cost of Revenue for 5 consecutive years, with $2.3 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cost of Revenue rose 4.35% year-over-year to $2.3 billion; the trailing twelve-month figure through Jun 2026 stood at $9.4 billion (up 11.63% YoY), and the FY2025 full-year result was $8.9 billion, up 8.11% from the prior year.
• Cost of Revenue declined to $2.3 billion in Q2 2026 per GEHC's latest filing, from $2.3 billion in the prior quarter.
• Across five years, Cost of Revenue topped out at $2.6 billion in Q4 2025 and bottomed at $1.9 billion in Q1 2022.
• Historically, Cost of Revenue has averaged $2.1 billion across 5 years, with a median of $2.1 billion in 2023.
• The sharpest annual moves came in 2024 and 2026: Cost of Revenue retreated 3.44% in 2024, then gained 16.3% in 2026.
• Over 5 years, Cost of Revenue stood at $2.2 billion in 2022, then increased by 5.49% to $2.3 billion in 2023, then dropped by 1.85% to $2.2 billion in 2024, then rose by 14.56% to $2.6 billion in 2025, then declined by 11.61% to $2.3 billion in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $2.3 billion, $2.3 billion, and $2.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.